| Code | Description | Claims | Beneficiaries | Total Paid |
| D0999 |
Unspecified diagnostic procedure, by report |
15,813 |
13,258 |
$4.23M |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12,965 |
11,355 |
$534K |
| D7140 |
Extraction, erupted tooth or exposed root |
1,942 |
977 |
$226K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
840 |
686 |
$150K |
| D0140 |
Limited oral evaluation - problem focused |
2,462 |
2,349 |
$111K |
| D1110 |
Prophylaxis - adult |
1,708 |
1,619 |
$95K |
| D0150 |
Comprehensive oral evaluation - new or established patient |
1,041 |
975 |
$51K |
| D0220 |
Intraoral - periapical first radiographic image |
2,720 |
2,570 |
$42K |
| 0012A |
|
1,102 |
984 |
$35K |
| 0011A |
|
1,525 |
1,095 |
$35K |
| D0120 |
Periodic oral evaluation - established patient |
868 |
836 |
$28K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
377 |
347 |
$19K |
| D0274 |
Bitewings - four radiographic images |
458 |
420 |
$19K |
| D0330 |
Panoramic radiographic image |
203 |
181 |
$14K |
| D1206 |
Topical application of fluoride varnish |
806 |
757 |
$12K |
| D2392 |
Resin-based composite - two surfaces, posterior, primary or permanent |
67 |
52 |
$11K |
| 0064A |
|
220 |
217 |
$8K |
| D0210 |
Intraoral - complete series of radiographic images |
66 |
66 |
$7K |
| D2391 |
Resin-based composite - one surface, posterior, primary or permanent |
34 |
24 |
$5K |
| D1120 |
Prophylaxis - child |
78 |
78 |
$3K |
| D1208 |
Topical application of fluoride, excluding varnish |
82 |
76 |
$2K |
| D0230 |
Intraoral - periapical each additional radiographic image |
129 |
125 |
$2K |
| 0013A |
|
40 |
40 |
$2K |
| D4910 |
|
13 |
13 |
$1K |
| D0270 |
|
83 |
72 |
$1K |
| 0071A |
|
25 |
24 |
$924.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
64 |
63 |
$840.85 |
| 0072A |
|
16 |
16 |
$672.00 |
| 59025 |
Fetal non-stress test |
19 |
14 |
$576.08 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
43 |
41 |
$397.44 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
78 |
42 |
$390.28 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
76 |
47 |
$327.10 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
1,348 |
640 |
$312.95 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
71 |
71 |
$5.00 |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
832 |
421 |
$0.00 |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
138 |
79 |
$0.00 |
| 99000 |
|
15 |
15 |
$0.00 |
| 90686 |
|
48 |
16 |
$0.00 |
| 97161 |
|
193 |
191 |
$0.00 |
| 99499 |
|
15 |
15 |
$0.00 |
| G0179 |
Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care |
43 |
42 |
$0.00 |
| 99374 |
|
13 |
12 |
$0.00 |
| G8511 |
Screening for depression documented as positive, follow-up plan not documented, reason not given |
16 |
16 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
36 |
12 |
$0.00 |